Factor Eight Inhibitor Bypassing Activity
Manufacturing · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1200 Lakeside Dr, Bannockburn, Illinois,...Website
www.feiba.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Factor Eight Inhibitor Bypassing Activity
FEIBA is an Anti-Inhibitor Coagulant Complex that has been utilized for over 40 years to support the treatment of patients with hemophilia A and B who have inhibitors. The product is designed to control and prevent bleeding episodes, and it is used during surgeries as well as for routine prophylaxis to reduce bleeding frequency. FEIBA has achieved a significant distribution milestone, with over 7 billion units supplied and 2 million patient treatments recorded. Its intended clients include healthcare professionals, patients, and caregivers in the U.S.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Factor Eight Inhibitor Bypassing Activity your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Factor Eight Inhibitor Bypassing Activity launches new products
Earning: See what the market has to say on Factor Eight Inhibitor Bypassing Activity recently announced quarterly report
Factor Eight Inhibitor Bypassing Activity, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Factor Eight Inhibitor Bypassing Activity has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Factor Eight Inhibitor Bypassing Activity is spiking on competitors!
Click to see if Factor Eight Inhibitor Bypassing Activity had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Factor Eight Inhibitor Bypassing Activity
Funding: Get notified immidiatlly once Factor Eight Inhibitor Bypassing Activity has new funding data
Recommended Actions
Reach out to Masked Content who joined Factor Eight Inhibitor Bypassing Activity as Masked Content
Find 3 more new buyers
Compare Similar Companies to Factor Eight Inhibitor Bypassing Activity
Compare insights from companies similar to Factor Eight Inhibitor Bypassing Activity, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Factor Eight Inhibitor By...
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Factor Eight Inhibitor Bypassing Activity is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Factor Eight Inhibitor Bypassing Activity is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Factor Eight Inhibitor Bypassing Activity.
Factor Eight Inhibitor Bypassing Activity Tech Stack
A closer look at the technologies used by Factor Eight Inhibitor Bypassing Activity
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Factor Eight Inhibitor Bypassing Activity
Sign Up For FreeTo access detailed company insights
FEIBA is an Anti-Inhibitor Coagulant Complex that has been utilized for over 40 years to support the treatment of patients with hemophilia A and B who have inhibitors. The product is designed to control and prevent bleeding episodes, and it is used during surgeries as well as for routine prophylaxis to reduce bleeding frequency. FEIBA has achieved... Read More
